{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:09:03Z","timestamp":1791925743605,"version":"4.3.4"},"reference-count":124,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Rural Development Administration, Republic of Korea","award":["PJ0081062011"],"award-info":[{"award-number":["PJ0081062011"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.gene.2014.05.031","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T05:05:50Z","timestamp":1400130350000},"page":"185-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Genetic markers for diagnosis and pathogenesis of Alzheimer's disease"],"prefix":"10.1016","volume":"545","author":[{"given":"Dong Hee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyeon","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Ye","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee Sun","family":"Ock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungwoo","family":"Eo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heui-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Jae","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2014.05.031_bb0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1474-4422(10)70323-9","article-title":"Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study","volume":"10","author":"Acosta-Baena","year":"2011","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.gene.2014.05.031_bb1111","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.arcmed.2012.10.017","article-title":"Genetics of Alzheimer's disease","volume":"43","author":"Alonso Vilatela","year":"2012","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.gene.2014.05.031_bb2222","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1073\/pnas.0503689102","article-title":"Neuronal sorting protein-related receptor sorLA\/LR11 regulates processing of the amyloid precursor protein","volume":"102","author":"Andersen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2014.05.031_bb0010","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-013-1111-z","article-title":"Clathrin adaptor CALM\/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains","volume":"125","author":"Ando","year":"2013","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.gene.2014.05.031_bb0015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","article-title":"Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms","volume":"86","author":"Andorfer","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.gene.2014.05.031_bb0020","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.286.18.2257","article-title":"A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families","volume":"286","author":"Athan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.gene.2014.05.031_bb0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1016\/j.gene.2014.05.031_bb0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/1354750X.2013.814073","article-title":"MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma","volume":"18","author":"Bekris","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/j.gene.2014.05.031_bb0035","first-page":"122","article-title":"Medical image. Angina bullosa haemorrhagica","volume":"123","author":"Bertram","year":"2010","journal-title":"New Zealand Medical Journal"},{"key":"10.1016\/j.gene.2014.05.031_bb0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.gene.2014.05.031_bb3333","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1074\/jbc.M807530200","article-title":"MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1","volume":"284","author":"Boissonneault","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2014.05.031_bb0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.gene.2014.05.031_bb0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L","article-title":"Apolipoprotein J (clusterin) and Alzheimer's disease","volume":"50","author":"Calero","year":"2000","journal-title":"Microscopy Research and Technique"},{"key":"10.1016\/j.gene.2014.05.031_bb0055","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.gene.2014.05.031_bb0060","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/353844a0","article-title":"Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene","volume":"353","author":"Chartier-Harlin","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.gene.2014.05.031_bb0065","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0914984107","article-title":"ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling","volume":"107","author":"Chen","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.gene.2014.05.031_bb0070","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.22277","article-title":"CR1 is associated with amyloid plaque burden and age-related cognitive decline","volume":"69","author":"Chibnik","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.gene.2014.05.031_bb0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/WAD.0b013e31826d7281","article-title":"Association of GWAS top hits with late-onset Alzheimer disease in Korean population","volume":"27","author":"Chung","year":"2013","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1016\/j.gene.2014.05.031_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","article-title":"Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways","volume":"14","author":"Cogswell","year":"2008","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.gene.2014.05.031_bb0085","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.05.031_bb0090","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/hmg\/5.Supplement_1.1449","article-title":"The presenilin genes: a new gene family involved in Alzheimer disease pathology","volume":"5","author":"Cruts","year":"1996","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.gene.2014.05.031_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/hmg\/7.1.43","article-title":"Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease","volume":"7","author":"Cruts","year":"1998","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.gene.2014.05.031_bb0095","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/humu.22117","article-title":"Locus-specific mutation databases for neurodegenerative brain diseases","volume":"33","author":"Cruts","year":"2012","journal-title":"Human Mutation"},{"key":"10.1016\/j.gene.2014.05.031_bb0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","article-title":"Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein","volume":"391","author":"De Strooper","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.gene.2014.05.031_bb4444","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1750-1326-6-70","article-title":"Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function","volume":"6","author":"Delay","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.gene.2014.05.031_bb5555","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.12437","article-title":"Alternative polyadenylation and miR-34 family members regulate tau expression","volume":"127","author":"Dickson","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.gene.2014.05.031_bb0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pneurobio.2012.06.004","article-title":"Good gene, bad gene: new APP variant may be both","volume":"99","author":"Di Fede","year":"2012","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.gene.2014.05.031_bb0115","first-page":"24","article-title":"Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers","volume":"6","author":"Dorval","year":"2013","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/j.gene.2014.05.031_bb6666","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxlet.2011.11.032","article-title":"The miR-124 regulates the expression of BACE1\/beta-secretase correlated with cell death in Alzheimer's disease","volume":"209","author":"Fang","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.gene.2014.05.031_bb0120","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.gene.2014.05.031_bb7777","doi-asserted-by":"crossref","first-page":"14820","DOI":"10.1523\/JNEUROSCI.3883-11.2011","article-title":"MicroRNA-137\/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease","volume":"31","author":"Geekiyanage","year":"2011","journal-title":"J. Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.gene.2014.05.031_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/bj2930027","article-title":"The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex","volume":"293","author":"Ghiso","year":"1993","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.gene.2014.05.031_bb0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-010-0747-1","article-title":"Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features","volume":"120","author":"Giaccone","year":"2010","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.gene.2014.05.031_bb0135","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2012.08.020","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. 1984","volume":"425","author":"Glenner","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2014.05.031_bb0140","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.gene.2014.05.031_bb0145","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.3810169","article-title":"Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease","volume":"235","author":"Goldgaber","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.05.031_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease","volume":"41","author":"Gomez-Isla","year":"1997","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.gene.2014.05.031_bb0155","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","article-title":"Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils","volume":"293","author":"Gotz","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.05.031_bb0160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.gene.2014.05.031_bb0165","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.05.031_bb0170","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nature Genetics"},{"key":"10.1016\/j.gene.2014.05.031_bb0175","series-title":"Circulating Nucleic Acids in Plasma and Serum","first-page":"275","article-title":"MicroRNA analysis in the spinal fluid of Alzheimer patients: a methodological feasibility study","author":"Harten","year":"2011"},{"key":"10.1016\/j.gene.2014.05.031_bb0180","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1093\/hmg\/ddq311","article-title":"Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration","volume":"19","author":"Hebert","year":"2010","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.gene.2014.05.031_bb8888","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tins.2008.12.003","article-title":"Alterations of the microRNA network cause neurodegenerative disease","volume":"32","author":"Hebert","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.gene.2014.05.031_bb0185","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1471-4159.2000.0751408.x","article-title":"Tau promoter confers neuronal specificity and binds Sp1 and AP-2","volume":"75","author":"Heicklen-Klein","year":"2000","journal-title":"Journal of Neurochemistry"},{"issue":"Suppl. 1","key":"10.1016\/j.gene.2014.05.031_bb0190","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.neurobiolaging.2011.09.003","article-title":"CSF biomarkers for Alzheimer's disease: current utility and potential future use","volume":"32","author":"Holtzman","year":"2011","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.gene.2014.05.031_bb0195","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1212\/WNL.0b013e3182515972","article-title":"Role of common and rare APP DNA sequence variants in Alzheimer disease","volume":"78","author":"Hooli","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.gene.2014.05.031_bb0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00401-005-1038-0","article-title":"The unfolded protein response is activated in Alzheimer's disease","volume":"110","author":"Hoozemans","year":"2005","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.gene.2014.05.031_bb9999","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s12264-013-1348-5","article-title":"MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1","volume":"29","author":"Hu","year":"2013","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.gene.2014.05.031_bb0205","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.gene.2014.05.031_bb0210","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1159\/000017187","article-title":"Tau immunoreactivity detected in human plasma, but no obvious increase in dementia","volume":"10","author":"Ingelson","year":"1999","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.gene.2014.05.031_bb1234","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2147\/CIA.S11718","article-title":"Late onset Alzheimer's disease in older people","volume":"5","author":"Isik","year":"2010","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.gene.2014.05.031_bb0215","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.410370305","article-title":"Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome","volume":"37","author":"Iwatsubo","year":"1995","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.gene.2014.05.031_bb0220","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.gene.2014.05.031_bb0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12035-013-8536-1","article-title":"CD33 in Alzheimer's disease","volume":"49","author":"Jiang","year":"2014","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.gene.2014.05.031_bb0230","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer's disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.gene.2014.05.031_bb0235","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/hmg\/dds054","article-title":"A coding variant in CR1 interacts with APOE-epsilon4 to influence cognitive decline","volume":"21","author":"Keenan","year":"2012","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.gene.2014.05.031_bb0240","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","article-title":"Complement receptor 1: disease associations and therapeutic implications","volume":"46","author":"Khera","year":"2009","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.gene.2014.05.031_bb0245","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1074\/jbc.M507753200","article-title":"Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs","volume":"281","author":"Khlistunova","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.gene.2014.05.031_bb0250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5114\/ninp.2013.33825","article-title":"Lack of association of CR1, PICALM and CLU gene polymorphisms with Alzheimer disease in a Polish population","volume":"47","author":"Klimkowicz-Mrowiec","year":"2013","journal-title":"Neurologia i Neurochirurgia Polska"},{"key":"10.1016\/j.gene.2014.05.031_bb0255","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1006\/bbrc.2000.2222","article-title":"Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma","volume":"268","author":"Kuo","year":"2000","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.gene.2014.05.031_bb0260","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-291X(89)92437-6","article-title":"Characterization of the 5\u2032-end region and the first two exons of the beta-protein precursor gene","volume":"159","author":"La Fauci","year":"1989","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.gene.2014.05.031_bb0265","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nature Genetics"},{"issue":"756","key":"10.1016\/j.gene.2014.05.031_bb0270","first-page":"e11","article-title":"Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations","volume":"32","author":"Lambert","year":"2011","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.gene.2014.05.031_bb0280","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/j.gene.2014.05.031_bb0275","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molmed.2005.02.008","article-title":"Tau phosphorylation in Alzheimer's disease: pathogen or protector?","volume":"11","author":"Lee","year":"2005","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.gene.2014.05.031_bb0285","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.05.031_bb0290","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JAD-2011-101917","article-title":"PICALM and CR1 variants are not associated with sporadic Alzheimer's disease in Chinese patients","volume":"25","author":"Li","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.gene.2014.05.031_bb0295","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1681\/ASN.2010090927","article-title":"MicroRNA 802 stimulates ROMK channels by suppressing caveolin-1","volume":"22","author":"Lin","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.gene.2014.05.031_bb0305","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neurobiolaging.2010.04.034","article-title":"MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice","volume":"33","author":"Liu","year":"2012","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.gene.2014.05.031_bb0300","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.gene.2014.05.031_bb0310","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L","article-title":"Defective ubiquitination of cerebral proteins in Alzheimer's disease","volume":"62","author":"Lopez Salon","year":"2000","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.gene.2014.05.031_bb0315","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/138920209788185252","article-title":"MicroRNA: implications for Alzheimer disease and other human CNS disorders","volume":"10","author":"Maes","year":"2009","journal-title":"Current Genomics"},{"key":"10.1016\/j.gene.2014.05.031_bb0320","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.gene.2014.05.031_bb0325","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.05.031_bb0330","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0896-6273(90)90342-D","article-title":"Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat","volume":"5","author":"May","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.gene.2014.05.031_bb0335","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1073\/pnas.112686799","article-title":"Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production","volume":"99","author":"Moehlmann","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.gene.2014.05.031_bb0340","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/156720511796391827","article-title":"The AICD interacting protein DAB1 is up-regulated in Alzheimer frontal cortex brain samples and causes deregulation of proteins involved in gene expression changes","volume":"8","author":"Muller","year":"2011","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.gene.2014.05.031_bb0345","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1925564","article-title":"A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease","volume":"254","author":"Murrell","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.05.031_bb0350","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1016\/j.gene.2014.05.031_bb0355","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fneur.2013.00083","article-title":"The importance of tau phosphorylation for neurodegenerative diseases","volume":"4","author":"Noble","year":"2013","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.gene.2014.05.031_bb0360","doi-asserted-by":"crossref","first-page":"39413","DOI":"10.1074\/jbc.M608485200","article-title":"Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles","volume":"281","author":"Oddo","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.gene.2014.05.031_bb0365","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/NEN.0b013e3182432967","article-title":"Mutant presenilin 2 increases beta-secretase activity through reactive oxygen species-dependent activation of extracellular signal-regulated kinase","volume":"71","author":"Park","year":"2012","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.gene.2014.05.031_bb2345","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-3-10","article-title":"MicroRNAs can regulate human APP levels","volume":"3","author":"Patel","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.gene.2014.05.031_bb0370","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1073\/pnas.092136199","article-title":"Tau is essential to beta-amyloid-induced neurotoxicity","volume":"99","author":"Rapoport","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.gene.2014.05.031_bb0375","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.05.031_bb0380","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.neurobiolaging.2005.09.043","article-title":"Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes","volume":"27","author":"Rogers","year":"2006","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.gene.2014.05.031_bb0385","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(96)90715-1","article-title":"Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation","volume":"347","author":"Rossor","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.gene.2014.05.031_bb0390","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.05.031_bb0395","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.1411576","article-title":"Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14","volume":"258","author":"Schellenberg","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.05.031_bb0400","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2217\/17520363.1.3.375","article-title":"Biomarker potential of heme oxygenase-1 in Alzheimer's disease and mild cognitive impairment","volume":"1","author":"Schipper","year":"2007","journal-title":"Biomarkers in Medicine"},{"key":"10.1016\/j.gene.2014.05.031_bb3456","doi-asserted-by":"crossref","first-page":"e11070","DOI":"10.1371\/journal.pone.0011070","article-title":"Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta","volume":"5","author":"Schonrock","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2014.05.031_bb5678","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12031-011-9587-2","article-title":"Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-beta","volume":"46","author":"Schonrock","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.gene.2014.05.031_bb0405","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI0216783","article-title":"Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease","volume":"110","author":"Selkoe","year":"2002","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.gene.2014.05.031_bb6789","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tcb.2004.12.004","article-title":"Recycle your receptors with retromer","volume":"15","author":"Seaman","year":"2005","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.gene.2014.05.031_bb0410","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.gene.2014.05.031_bb9876","doi-asserted-by":"crossref","first-page":"590","DOI":"10.18632\/aging.100486","article-title":"Plasma microRNA biomarkers for detection of mild cognitive impairment","volume":"4","author":"Sheinerman","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.gene.2014.05.031_bb0415","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.gene.2014.05.031_bb0420","first-page":"693","article-title":"Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues","volume":"64","author":"Shin","year":"1991","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.gene.2014.05.031_bb0425","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.maturitas.2010.06.017","article-title":"A susceptible haplotype within APOE gene influences BMD and intensifies the osteoporosis risk in postmenopausal women of Northwest India","volume":"67","author":"Singh","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.gene.2014.05.031_bb8765","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archneurol.2007.64","article-title":"Retromer sorting: a pathogenic pathway in late-onset Alzheimer disease","volume":"65","author":"Small","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.gene.2014.05.031_bb7654","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuron.2006.09.001","article-title":"Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis","volume":"52","author":"Small","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.gene.2014.05.031_bb6543","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.20667","article-title":"Model-guided microarray implicates the retromer complex in Alzheimer's disease","volume":"58","author":"Small","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.gene.2014.05.031_bb5432","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1471-4159.2010.07097.x","article-title":"In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs","volume":"116","author":"Smith","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.gene.2014.05.031_bb0430","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0162-3109(00)80303-3","article-title":"Complement and innate immunity","volume":"49","author":"Song","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.gene.2014.05.031_bb0435","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0952-7915(91)90028-Y","article-title":"Lymphokines and the immune response: the central role of interleukin-2","volume":"3","author":"Swain","year":"1991","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.gene.2014.05.031_bb0440","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jalz.2012.08.007","article-title":"Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population","volume":"9","author":"Tan","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.gene.2014.05.031_bb0445","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2013.06.004","article-title":"Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease","volume":"19","author":"Tan","year":"2013","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.gene.2014.05.031_bb0450","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00019052-200008000-00003","article-title":"Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins","volume":"13","author":"Tandon","year":"2000","journal-title":"Current Opinion in Neurology"},{"key":"10.1016\/j.gene.2014.05.031_bb0455","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neuropharm.2010.04.006","article-title":"Biomarkers in translational research of Alzheimer's disease","volume":"59","author":"Tarawneh","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.gene.2014.05.031_bb0460","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","article-title":"Alzheimer's disease facts and figures","volume":"9","author":"Thies","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.gene.2014.05.031_bb0465","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1073\/pnas.1315110110","article-title":"Adaptor complex AP2\/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy","volume":"110","author":"Tian","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Suppl. 5","key":"10.1016\/j.gene.2014.05.031_bb0470","first-page":"S81","article-title":"Determination of the Apo E genotype using LightCycler Apo E mutation detection kit","volume":"92","author":"Tirawanchai","year":"2009","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1016\/j.gene.2014.05.031_bb2468","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1471-4159.2003.01597.x","article-title":"Employing a superior BACE1 cleavage sequence to probe cellular APP processing","volume":"84","author":"Tomasselli","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.gene.2014.05.031_bb0475","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.21321","article-title":"A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia","volume":"63","author":"Tomiyama","year":"2008","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.gene.2014.05.031_bb0480","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-122263","article-title":"Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease","volume":"35","author":"Villa","year":"2013","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.gene.2014.05.031_bb0485","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000090631","article-title":"CSF biomarkers for Alzheimer's disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival","volume":"21","author":"Wallin","year":"2006","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.gene.2014.05.031_bb1357","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1242\/jcs.03302","article-title":"A loss-of-function screen reveals SNX5 and SNX6 as potential components of the mammalian retromer","volume":"120","author":"Wassmer","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.gene.2014.05.031_bb0490","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1471-4159.1997.69010388.x","article-title":"Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide","volume":"69","author":"Webster","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.gene.2014.05.031_bb0495","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10048-006-0043-3","article-title":"Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing early-onset Alzheimer's disease in Mexican families","volume":"7","author":"Yescas","year":"2006","journal-title":"Neurogenetics"},{"key":"10.1016\/j.gene.2014.05.031_bb0500","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12035-012-8237-1","article-title":"The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy","volume":"45","author":"Yu","year":"2012","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.gene.2014.05.031_bb3579","first-page":"189","article-title":"Natural compounds that modulate BACE1-processing of amyloid-beta precursor protein in Alzheimer's disease","volume":"14","author":"Zhang","year":"2012","journal-title":"Discov. Med."},{"key":"10.1016\/j.gene.2014.05.031_bb0505","doi-asserted-by":"crossref","first-page":"232","DOI":"10.55782\/ane-2009-1748","article-title":"Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease","volume":"69","author":"Zekanowski","year":"2009","journal-title":"Acta Neurobiologiae Experimentalis (Wars)"},{"key":"10.1016\/j.gene.2014.05.031_bb0510","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1073\/pnas.93.9.4229","article-title":"Glycoprotein 330\/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood\u2013brain and blood\u2013cerebrospinal fluid barriers","volume":"93","author":"Zlokovic","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111914005794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111914005794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:16:44Z","timestamp":1759853804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111914005794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0378111914005794"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2014.05.031","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic markers for diagnosis and pathogenesis of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2014.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}